Ordinary Share Capital Endring Dato
AbbVie USD 18M 0 2023-09
Amgen USD 32.75B 152M 2023-09
Arrowhead Research USD 200K 0 2023-12
AstraZeneca USD 387M 0 2023-09
Biogen USD 100K 0 2023-12
Bristol-Myers Squibb USD 292M 0 2023-09
Gilead Sciences USD 1000K 0 2023-09
GlaxoSmithKline GBP 1.35B 0 2023-09
Halozyme Therapeutics USD 127K 5K 2023-12
Heron Therapeutics USD 1.41M 212K 2023-09
Immunic USD 4K 0 2023-09
Incyte USD 224K 0 2023-12
Insmed USD 1.48M 50K 2023-12
Ionis Pharmaceuticals USD 144K 1000 2023-12
J&J USD 3.12B 0 2023-09
Ligand Pharmaceuticals USD 18K 0 2023-12
Marinus Pharmaceuticals USD 55K 4K 2023-09
Merck USD 1.79B 0 2023-09
Neurocrine Biosciences USD 100K 0 2023-09
Novartis USD 825M 17M 2023-09
Novavax USD 1.2M 244K 2023-09
Pfizer USD 478M 0 2023-09
PTC Therapeutics USD 75K 0 2023-12
Roche Holding CHF 107M 0 2023-06
Sarepta Therapeutics USD 9K 0 2023-09
Vertex Pharmaceuticals USD 2.6M 0 2023-09



Enanta Pharmaceuticals Ordinære Aksjekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.